Promoter holding
64.27%
TI
Tristar Intermediates Private Limited - Due diligence report
A 360° intelligence report on Tristar Intermediates: trust score, financial health, credit view, compliance, directors, growth and distress …
Full Due-Diligence Report + Documents
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
₹700
₹449
Save ₹251
excl. GST
Or from ₹279/report with credits
View credit packages
Company Credits – Starter
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Choose your own credit amount
View credit packages
Tristar Intermediates — 360° Intelligence Report
Generated from MCA filings & public records92/100
Trust Score
Low Risk
Tristar Intermediates is assessed as Low Risk with a Trust Score of 92/100. Tristar Intermediates is an active private limited indian non-government company incorporated in 1997, operating in the Chemicals and Materials sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and low financial risk profile.
Report generated on 18 Jul 2026 from the latest processed filings. Tristar Intermediates Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
02
Score Card
Higher is safer · rule-based & explainableTrust ScoreLow Risk
92/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
86/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
95/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
80/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03
Financial Intelligence Dashboard
Standalone · 5 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
04
Credit & Compliance Intelligence
Why the scores are what they are
Credit Risk Score: 95/100 Low Risk
- Liabilities ≈ 38% EBITDA - serviceable.
- Moderate gearing (D/E 1.42).
- Working-capital cover adequate.
- Profitable - internal accruals available.
Charges position: 1 open (40.00 cr) · 2 satisfied (26.17 cr).
Banking relationships (from registered charges)
| Lender | Charges | Amount |
|---|---|---|
| Axis Bank Limited | 1 | 48.0 cr |
| State Bank Of India | 2 | 48.0 cr |
Compliance Score: 86/100 Low Risk
- Company status is Active as per MCA.
- Annual filings current (balance sheet Mar 2025).
- Litigation present in 2 court forum(s).
- 2 active GST registration(s).
Legal cases on record (2)
05
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| MIKHAIL MENEZES | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| YASH SUNIL CHARI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| MEHER BRUNO CASTELINO | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SUNIL SRINIVASAN CHARI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| GURUDAS VISHWAS ARAS | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| EDWARD WALTER MENEZES | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SANJAY RAMAKRISHNA MARBALLI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| KRISHNA KUMAR TIWARI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 8 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
06
Ownership & Group Intelligence
As per FY 2023 annual returnPublic / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
Rossari Biotech Limited
Subsidiaries
-
Group entities
-
Capital events
2 allotment(s) · 0 transfer(s)
Promoters hold a dominant controlling stake - exact percentages are part of the full report.
| Group entity | Relationship | % held |
|---|---|---|
| Rossari Biotech Limited | Holding Company | 74.00% |
Key managerial personnel: SANJAY RAMAKRISHNA MARBALLI (Whole-time director) · KRISHNA KUMAR TIWARI (Whole-time director)
Full shareholding pattern, group structure & capital events →
07
Risk Intelligence Center
Growth 80 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Latest year revenue grew 24%.
Operating for 28+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
1 open charge(s) registered - assets are encumbered.
2 court case(s) on record - see the legal section for details.
08
Stakeholder Verdicts
Vendor · Banker · InvestorVendor due diligence89/100
Favourable indicators
Suitability as a supplier / customer counterparty.
- Statutory record is clean.
- No distress signals on file.
- Financial filings available for verification.
Banker assessment93/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
- Debt capacity assessed from filed statements.
- 1 open charge(s) of 40.00 cr already registered.
- Compliance record supports lending.
Investor view88/100
Positive growth indicators
Growth quality and scalability through an investor lens.
- 2 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
09
MCA Filings & Events Timeline
Latest 15 events11 Jun 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
09 Sep 2022
Charge satisfied
State Bank Of India
08 Jul 2022
Director ceased
MEHER BRUNO CASTELINO
Director ceased
GURUDAS VISHWAS ARAS
22 Nov 2021
Director appointed
MEHER BRUNO CASTELINO (Director)
Director appointed
GURUDAS VISHWAS ARAS (Director)
17 Nov 2021
Charge created
Axis Bank Limited - 40.00 cr
03 Sep 2021
Director ceased
MIKHAIL MENEZES
Director ceased
YASH SUNIL CHARI
Director ceased
SUNIL SRINIVASAN CHARI
Director ceased
EDWARD WALTER MENEZES
01 Sep 2021
Director appointed
MIKHAIL MENEZES (Director)
Director appointed
YASH SUNIL CHARI (Director)
Director appointed
SUNIL SRINIVASAN CHARI (Director)
10
Key Observations
Auto-generated from the data aboveRevenue grew 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
Debt-to-equity stands at 1.42 - manageable leverage.
Net worth is positive.
Compliance record is strong - status, filings and flags are clean.
8 active director(s) / partner(s); board looks stable and experienced.
2 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 2 security allotment(s) - amounts available in the full report.
| Company | CIN | Location |
|---|---|---|
| Savla Chemicals Limited | U24100MH1995PLC094465 | Mumbai, Maharashtra, India |
| Martin And Harris Laboratories Limited | U24239HR1993PLC033630 | Na, Haryana, India |
| Tricom Agro Private Limited | U24120TG1995PTC021438 | Sangareddy Dist Erstwhile Medak Dist, Telangana, India |
| Travancore Titanium Products | U13209KL1946SGC001214 | Trivandrum, Kerala, India |
| Lalitha Chem Industries Private Limited | U24100MH1990PTC059381 | Vasai City, Maharashtra, India |
| Premcem Gums Private Limited | U65990MH1960PTC011785 | Mumbai, Maharashtra, India |
| Abaris Healthcare | U74900DL2009PTC188425 | New Delhi, Delhi, India |
| Cabot Sanmar | U93090TN1996PLC034761 | Tamilnadu, Tamil Nadu, India |
12
Who Uses This Report
CA · CS · Banker · Investor · VendorChartered Accountants (CA)
Verify Tristar Intermediates before audits and certifications: compliance score 86/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Company Secretaries (CS)
Track statutory health of Tristar Intermediates: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Bankers & NBFCs
Current banker verdict: Favourable lending indicators. Credit risk score 95/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investors & Analysts
Investor view: Positive growth indicators. Growth score 80/100, margin trends, ownership structure and peer set for Tristar Intermediates - screening before a deeper diligence.
Vendors & Procurement Teams
Vendor verdict: Favourable indicators. Trust score 92/100, distress signals and MSME payment-delay disclosures - know whether Tristar Intermediates pays its suppliers before you extend credit terms.
Lawyers & Compliance Teams
Litigation footprint (2 case(s) on record), regulatory flags, charge documents trail and director networks for Tristar Intermediates - groundwork for KYC, onboarding and disputes.
13
Frequently Asked Questions
Is Tristar Intermediates an active company?
Tristar Intermediates has MCA status “Active” with a compliance score of 86/100 (Low Risk).
Is Tristar Intermediates financially healthy?
Tristar Intermediates has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.
Should I do business with Tristar Intermediates?
Its overall Trust Score is 92/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Tristar Intermediates?
The ultimate holding entity is Rossari Biotech Limited. 8 active director(s) are on record.
Does Tristar Intermediates have loans or charges against its assets?
1 open charge(s) are registered against its assets, and 2 earlier charge(s) stand satisfied.
Is Tristar Intermediates up to date with its ROC filings?
Annual filings current (balance sheet Mar 2025). Overall compliance score: 86/100 (Low Risk).
Is it risky to lend to Tristar Intermediates?
Its Credit Risk Score is 95/100 (Low Risk). Banker verdict: Favourable lending indicators.
Disclaimer: This report is generated automatically from MCA filings and public records as available
in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the
underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are
not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice.
Verify from official sources and consult a qualified professional before any business, lending or investment decision.
If you represent this company and believe any information is inaccurate or outdated,
report it here and we will review promptly.
